Company Filing History:
2 out of 1,119 
2 out of 192 
2 out of 8,686 
Years Active: 2024
Title: Allen Duplantier: Innovator in Antiviral Research
Introduction
Allen Duplantier is a notable inventor based in Stafford, VA (US), recognized for his contributions to antiviral research. He holds 2 patents that focus on innovative treatments for respiratory diseases caused by coronaviruses. His work is particularly relevant in the context of global health challenges posed by viruses such as SARS-CoV-2.
Latest Patents
Duplantier's latest patents include inhibitors for coronavirus, specifically targeting SARS-CoV-1, SARS-CoV-2 (Covid-19), MERS-CoV, and their variants. These patents detail methods for treating subjects suffering from these respiratory diseases. Additionally, he has developed antiviral drugs that target the N-terminal domain (NTD) of the coronavirus spike receptor binding domain (RBD), providing further methods for treating individuals affected by coronavirus.
Career Highlights
Throughout his career, Allen Duplantier has worked with esteemed organizations such as the Southwest Research Institute and the Henry M. Jackson Foundation for the Advancement of Military Medicine Inc. His experience in these institutions has significantly contributed to his expertise in antiviral research and development.
Collaborations
Duplantier has collaborated with notable colleagues, including Jonathan A Bohmann and Nadean M Gutierrez. These partnerships have likely enhanced the scope and impact of his research efforts.
Conclusion
Allen Duplantier's innovative work in antiviral research, particularly concerning coronaviruses, showcases his commitment to addressing critical health issues. His patents and collaborations reflect a significant contribution to the field of medicine and public health.